{"id":59861,"date":"2026-09-15T19:46:15","date_gmt":"2026-09-15T14:16:15","guid":{"rendered":"https:\/\/financialtelegraph.in\/index.php\/2026\/09\/15\/furlicks-goes-from-6-to-22-skus-fredun-pharmaceuticals-ltd-accelerates-pet-wellness-expansion\/"},"modified":"2026-09-15T19:46:15","modified_gmt":"2026-09-15T14:16:15","slug":"furlicks-goes-from-6-to-22-skus-fredun-pharmaceuticals-ltd-accelerates-pet-wellness-expansion","status":"publish","type":"post","link":"https:\/\/financialtelegraph.in\/index.php\/2026\/09\/15\/furlicks-goes-from-6-to-22-skus-fredun-pharmaceuticals-ltd-accelerates-pet-wellness-expansion\/","title":{"rendered":"Furlicks Goes from 6 to 22 SKUs: Fredun Pharmaceuticals Ltd. Accelerates Pet Wellness Expansion"},"content":{"rendered":"
\n

\"Furlicks\"<\/p>\n

Mumbai (Maharashtra) [India], September 15:<\/strong> Fredun Pharmaceuticals Limited (FPL) is charting the next phase of growth for Furlicks with\u00a0a significant phase-wise portfolio expansion<\/strong>\u00a0following its acquisition of the pet-wellness brand.\u00a0Over the next 6 -9 months, FPL plans to introduce<\/strong>\u00a016 new products,<\/strong>\u00a0taking the brand from its existing six-SKU oral-strip portfolio to\u00a022 SKUs in the first phase.<\/strong><\/p>\n

Furlicks currently addresses a range of pet wellness needs, from\u00a0skin and coat and gut health to joint care, calming, oral care and multivitamins.<\/strong>\u00a0The upcoming portfolio will build on this foundation, taking the brand beyond oral strips into a broader range of\u00a0pet wellness and functional nutrition formats.\u00a0<\/strong>It will include\u00a0dissolving strips, cold-extruded, air-dried and freeze-dried products, alongside functional biscuits.<\/strong>\u00a0This expansion will allow Furlicks to engage with a wider range of pet-care occasions while strengthening its proposition around convenience, innovation and everyday wellness.<\/p>\n

While the acquisition marked FPL\u2019s strategic entry into the pet-wellness category, the upcoming product expansion marks the\u00a0next step in Fredun Pharmaceutical Ltd.\u2019s ambition to build Furlicks into a differentiated, multi-format pet-wellness platform<\/strong>.<\/p>\n

Speaking on the expansion, Mr. Fredun Medhora, MD & CFO, Fredun Pharmaceuticals Ltd., said,<\/strong>\u00a0\u201cWe did not acquire Furlicks to simply add another brand to our portfolio; we acquired it because we saw the potential to build a meaningful pet-wellness business around a differentiated proposition. The next 6 \u2013 9 months are about turning that potential into scale. With 16 new products across multiple formats, we are expanding Furlicks\u2019 role in the everyday lives of pets while bringing\u00a0FPL\u2019s strengths in manufacturing, R&D, and product development to accelerate innovation.<\/strong>\u00a0Our ambition is to build Furlicks into a truste<\/em>d, accessible and relevant holistic\u00a0pet-wellness brand\u00a0<\/strong>for millions of pet parents across India.\u201d<\/p>\n

With Furlicks already available online across India, the next phase will focus on\u00a0deepening the portfolio, expanding formats and strengthening accessibility<\/strong>, using FPL\u2019s strengths, allowing the brand to engage with pet parents across a wider range of everyday wellness occasions.<\/p>\n

The first phase of 16 new launches is a peek into\u00a0Furlicks\u2019 larger product roadmap,\u00a0<\/strong>establishing the foundation for the brand\u2019s next stage of growth. While the brand\u2019s core promise of making pet care\u00a0simpler, more convenient, and easier for pet parents<\/strong>will be retained \u2013 FPL is also focusing on developing Furlicks into a\u00a0comprehensive, innovation-led pet-wellness platform for the Indian market<\/strong>.<\/p>\n

About Fredun Pharmaceuticals Limited<\/strong><\/h3>\n

Fredun Pharmaceuticals Limited (FPL) is a legacy brand in the healthcare segment with expertise spanning across four decades, with a focus on pharmaceuticals, healthcare, consumer-facing wellness and specialised healthcare categories. Through its businesses and subsidiaries, FPL continues to build capabilities across product development, manufacturing, distribution, and consumer-focused healthcare solutions.<\/p>\n

About Furlicks<\/strong><\/h3>\n

Furlicks is a pet-wellness brand focused on making everyday pet care simpler and more convenient through innovative oral-strip solutions. Its portfolio spans categories including skin and coat, gut health, joint care, calming, oral care and multivitamins, with a focus on convenient formats designed around the needs of modern pet parents.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Mumbai (Maharashtra) [India], September 15: Fredun Pharmaceuticals Limited (FPL) is charting the next phase of growth for Furlicks with\u00a0a significant phase-wise portfolio expansion\u00a0following its acquisition of the pet-wellness brand.\u00a0Over the … Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":59862,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[448],"class_list":["post-59861","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business","entry"],"_links":{"self":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/59861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/comments?post=59861"}],"version-history":[{"count":0,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/59861\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media\/59862"}],"wp:attachment":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media?parent=59861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/categories?post=59861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/tags?post=59861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}